It remains controversial whether the routes from somatic cells to induced pluripotent stem cells (iPSCs) are related to the reverse order of normal developmental processes. Specifically, it remains unaddressed whether or not the differentiated cells become iPSCs through their original tissue stem cell-like state. Previous studies analyzing the reprogramming process mostly used fibroblasts; however, the stem cell characteristics of fibroblasts made it difficult to address this. Here, we generated iPSCs from mouse astrocytes, a type of glial cells, by three (OCT3/4, KLF4, and SOX2), two (OCT3/4 and KLF4), or four (OCT3/4, KLF4, and SOX2 plus c-MYC) factors. Sox1, a neural stem cell (NSC)-specific transcription factor, is transiently up-regulated during reprogramming, and Sox1-positive cells become iPSCs. Somatic cells can be reprogrammed into a pluripotent state through ectopic expression of defined transcription factors, such as Oct3/4, Klf4, Sox2, and c-Myc (OKSM) 4 (1). Since the generation of induced pluripotent stem cells (iPSCs), many studies have been done to elucidate the mechanism and nature of molecular changes underlying the reprogramming process (2). However, many questions still remain unanswered. One of the fundamental questions to be answered is whether reprogramming reverses normal developmental processes or not. A recent report showed that human somatic cells are reprogrammed through a mesendoderm-like state (3). In contrast, several reports demonstrated that cells in the intermediate state of fibroblast reprogramming express developmental regulators and cell type-specific genes that are not involved in the fibroblast lineage (4 -6). In addition, several reports have shown transient expression of epidermis genes during fibroblast reprogramming (7-9). These results suggest that the reprogramming process is not simply the reversal of normal developmental processes. However, it remains unclear whether the routes to iPSCs are related to the reverse order of normal developmental processes, and thus, it also remains unknown whether differentiated cells become iPSCs through their original tissue stem cell-like state or not.Most previous studies dealing with the reprogramming process used mouse embryonic fibroblasts (MEFs) (10 -13), which are heterogeneous and contain both mesenchymal and non-mesenchymal cells. Moreover, MEFs themselves are a type of tissue stem cell, and the cell lineage of MEFs is largely unknown. Therefore, the use of MEFs as donor cells may not be suitable for the study addressing the question of whether or not differentiated cells become iPSCs through their original tissue stem cell-like state.It has been reported that various types of cells can be reprogrammed to iPSCs (14). However, the characteristics of intermediate-state cells during reprogramming from donor cell types other than MEFs have been poorly understood. In this study, we used mouse astrocytes. Astrocytes are a type of glial cells, which are differentiated from neural stem cells (NSCs), and embryonic stem cells (ESCs) d...